InvestorLens

CGTX — COGNITION THERAPEUTICS INC

Public company

Sign in to save2 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About COGNITION THERAPEUTICS INC (CGTX)

COGNITION THERAPEUTICS INC (CGTX) appears in the most recent 13F filings of 2 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $217,621. Across recent filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in CGTX

100
/100
Strong Institutional Accumulation
Added / Increased1
Reduced0
Exited0
BearishBullish
Crowded Trade Score™

How many top investors track CGTX

13
/100
Undiscovered
2investors

Only 2 tracked investors report this position.

UndiscoveredCrowded
151015+

CGTX Ownership Composition

How COGNITION THERAPEUTICS INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Other
100% of tracked value
Institutions
2
tracked investors
Total Reported
$107K
combined 13F value
Sectors1
  • Other100.0%
Other(2)
100.0%

Tracked investors reporting CGTX

  • Ken GriffinMar 31, 2026
    Citadel Advisors
    Shares
    25.9K
    Value
    $19.7K
    % Portfolio
    0.00%
  • Izzy EnglanderDec 31, 2025
    Millennium Management
    Shares
    64.7K
    Value
    $87.3K
    % Portfolio
    0.00%

Recent activity

Frequently asked questions

How many institutional investors hold CGTX?
2 tracked institutional investors disclosed a position in CGTX (COGNITION THERAPEUTICS INC) in their most recent 13F filing.
Who is the largest institutional holder of CGTX?
Ken Griffin, Citadel Advisors, holds the largest disclosed position in CGTX, valued at $217,621.
Did institutional ownership of CGTX increase or decrease?
Across recent 13F filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 fully exited CGTX.
Where does this CGTX ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.
CGTX (COGNITION THERAPEUTICS INC) — Institutional Holders & — InvestorLens